Figure 3
Survival comparison between patients with CML with 3q26.2 abnormalities as the sole ACA and patients with CML with other single ACAs.

Survival comparison between patients with CML with 3q26.2 abnormalities as the sole ACA and patients with CML with other single ACAs.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal